Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma Antigens

Documenti analoghi

• Cloning and Characterization of the Genes Encoding the Murine Homologues of the Human Melanoma Antigens MART1 and gp100
  di: Zhai, Yifan, et al.
  Pubblicazione: (1997)
• Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen
  di: Rosenberg, Steven A., et al.
  Pubblicazione: (2003)
• Recombinant Fowlpox Viruses Encoding the Anchor-modified gp 100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma
  di: Rosenberg, Steven A., et al.
  Pubblicazione: (2003)
• Impact of Cytokine Administration on the Generation of Antitumor Reactivity in Patients with Metastatic Melanoma Receiving a Peptide Vaccine
  di: Rosenberg, Steven A., et al.
  Pubblicazione: (1999)
• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
  di: Rosenberg, Steven A., et al.
  Pubblicazione: (1998)